Fluticasone Propion/Salmeterol
Brand name: Advair Diskus
Rank #35 of 500 drugs by total cost
$523.2M
Total Cost
1,289,942
Total Claims
$523.2M
Total Cost
55,882
Prescribers
$406
Cost per Claim
134,015
Beneficiaries
1,836,493
30-Day Fills
$9,362
Avg Cost/Provider
23
Avg Claims/Provider
About Fluticasone Propion/Salmeterol
Fluticasone Propion/Salmeterol (sold as Advair Diskus) was prescribed 1,289,942 times by 55,882 Medicare Part D providers in 2023, costing the program $523.2M. At $406 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 32 | Lipase/Protease/Amylase (Zenpep) | $577.7M | 321,809 |
| 33 | Insulin Degludec (Tresiba Flextouch U-100) | $567.8M | 597,178 |
| 34 | Valbenazine Tosylate (Ingrezza) | $553.8M | 73,914 |
| 35 | Fluticasone Propion/Salmeterol (Advair Diskus) | $523.2M | 1,289,942 |
| 36 | Varicella-Zoster Ge/As01b/Pf (Shingrix) | $514.4M | 2,419,884 |
| 37 | Tafamidis (Vyndamax) | $511.1M | 20,589 |
| 38 | Fluticasone/Vilanterol (Breo Ellipta) | $493.0M | 909,837 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology